COLCHICINE FOR PREVENTION OF POST-PROCEDURAL ATRIAL FIBRILLATION: A META-ANALYSIS  by Lee, Justin Z. et al.
Arrhythmias and Clinical EP
A376
JACC March 17, 2015
Volume 65, Issue 10S
ColChiCinE for prEVEntion of post-proCEdural atrial fibrillation: a MEta-analysis
Poster Contributions
Poster Hall B1
Sunday, March 15, 2015, 9:45 a.m.-10:30 a.m.
Session Title: What Constitutes Anti Arrhythmic Therapy for Atrial Fibrillation?
Abstract Category: 4. Arrhythmias and Clinical EP: AF/SVT
Presentation Number: 1186-239
Authors: Justin Z. Lee, Nirmal Singh, Jennifer Huang, Carol Howe, Gilbert Ortega, Simin Golestani, See Wei Low, Kwan Lee, Anil Pandit, 
University of Arizona, Tucson, AZ, USA, DeBakey Heart Institute, Hays, KS, USA
background: Pro-inflammatory processes induced during invasive cardiac procedures may contribute towards post-procedural atrial 
fibrillation. Colchicine is a potent anti-inflammatory agent, which may have a role in post-procedural atrial fibrillation prevention. This meta-
analysis aims to assess the role of colchicine in post-procedural prevention of atrial fibrillation.
Methods: We searched PubMed, EMBASE, Web of science and the Cochrane Central Register of Controlled Trials databases for 
randomized controlled trials (RCT) comparing colchicine versus placebo for prevention of post-procedural atrial fibrillation. Our main 
outcome was the occurrence of atrial fibrillation within 1 to 3 months post procedure, which included cardiac surgery or pulmonary vein 
isolation. The overall risk ratio (RR) for the development of post-procedural atrial fibrillation was computed using a random-effects model.
results: Data analyzed from 5 randomized studies with a total of 1,369 patients, 641 patients received colchicine and 638 patients 
received placebo, showed that colchicine therapy was associated with a reduction of post-procedural atrial fibrillation (MH-RR=0.63, 95% 
CI: 0.51-0.78, p<0.0001).
Conclusion:  Colchicine therapy leads to a significant reduction in post-procedural atrial fibrillation, and may be considered as adjunctive 
prophylaxis.
 
